Larimar Therapeutics, Inc. LRMR
2.54 USD +0.17 (+7.17%)
At closeNov 3, 2026, 4:01 PM EST
2.54 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
2.37 Day range 2.62
1.92 52-week range 6.42
- YTD
- -33.33%
- 1 year
- -34.54%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 20.41 +703.5% upside
Now 2.54
- Target (low)
- 12.49
- Target (mean)
- 20.41
- Target (high)
- 36.00
Ratings (0m) 11 11 buy · 0 hold · 0 sell
- Strong buy2
- Buy9
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 11
- 2 months ago 11
- 3 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.32491 | -0.45 – -0.25 | -0.29 | -12.0% | 0 | 0.0% | 9 |
| Next quarter | -0.38576 | -0.50 – -0.33 | -0.27 | -42.9% | 0 | 0.0% | 4 |
| Current year | -1.23 | -1.49 – -1.11 | -0.84 | -46.1% | 0 | 0.0% | 9 |
| Next year | -1.68 | -2.20 – -1.26 | -1.23 | -37.2% | 0 | 0.0% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 31, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 16, 2024 | Oppenheimer | Initiated | — | Outperform |
| Oct 3, 2024 | Wedbush | Initiated | — | Outperform |
| Oct 2, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Sep 12, 2024 | Jones Trading | Initiated | — | Buy |
| Sep 4, 2024 | Baird | Initiated | — | Outperform |
| May 31, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| May 22, 2024 | Citigroup | Maintained | Buy | Buy |
| May 21, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Apr 3, 2024 | Leerink Partners | Initiated | — | Outperform |
| Mar 15, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Mar 12, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Feb 13, 2024 | Citigroup | Maintained | Buy | Buy |
| Feb 13, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Nov 17, 2023 | Citigroup | Upgrade | Neutral | Buy |
| Aug 15, 2023 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| May 18, 2023 | Citigroup | Maintained | Neutral | Neutral |
| May 17, 2023 | Guggenheim | Maintained | Buy | Buy |
| May 16, 2023 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| May 15, 2023 | Citigroup | Maintained | Neutral | Neutral |
| Mar 15, 2023 | Guggenheim | Reiterated | — | Buy |
| Mar 14, 2023 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Mar 1, 2023 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Jan 24, 2023 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Dec 13, 2022 | Citigroup | Initiated | — | Neutral |
| Oct 19, 2022 | Guggenheim | Initiated | — | Buy |
| Sep 19, 2022 | JMP Securities | Maintained | — | Market Outperform |